Quick Answer
PepGen Inc. reported Research And Development Expense of $71.04 million for the year ending 2025.
- PepGen Inc. showed a decrease of -7.1% in Research And Development Expense from 2024 to 2025.
- This data is from PepGen Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $5.53 million | Q2 2021: $3.22 million | Q3 2021: $5.71 million | Q1 2022: $10.71 million | Q2 2022: $14.24 million | Q3 2022: $15.96 million | Q1 2023: $14.36 million | Q2 2023: $16.93 million | Q3 2023: $20.54 million | Q1 2024: $14.73 million | Q2 2024: $25.06 million | Q3 2024: $17.72 million | Q1 2025: $25.38 million | Q2 2025: $18.39 million | Q3 2025: $13.42 million.
- Over the full 5 years of available data (2021 to 2025), PepGen Inc.'s Research And Development Expense has grown by 273.9%.
- Historical annual values: Fiscal year 2025: $71.04 million | Fiscal year 2024: $76.48 million | Fiscal year 2023: $68.13 million | Fiscal year 2022: $54.08 million | Fiscal year 2021: $19.00 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: